Thomas C Shea MD
Professor of Medicine, University of North Carolina School of Medicine
Join to View Full Profile
101 Manning DrChapel Hill, NC 27514
Phone+1 919-966-4996
Fax+1 919-843-5515
Dr. Shea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1981 - 1982
University of North Carolina at Chapel Hill School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1988 - Present
NC State Medical License 1979 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer Start of enrollment: 1997 Sep 01
- SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1997 Jul 01
- Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma Start of enrollment: 2001 Feb 01
Publications & Presentations
PubMed
- 16 citationsAnti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30lymphoma: a phase 1 study.Natalie S Grover, George Hucks, Marcie L Riches, Anastasia Ivanova, Dominic T Moore
The Lancet. Haematology. 2024-05-01 - 1 citations"Success is dependent on prevention and early detection" - A Conversation with Oncologist and Researcher Dr. Thomas C. Shea.Peter J Morris, Thomas C Shea
North Carolina Medical Journal. 2023-09-01 - 3 citationsImpact of patient and clinical characteristics on cognitive changes after allogeneic hematopoietic stem cell transplantation.Zev M. Nakamura, Hillary M. Heiling, Eliza M. Park, Allison M. Deal, Laura J. Quillen
Bone Marrow Transplantation. 2021-10-02
Journal Articles
- Mature Outcomes and Prognostic Indices in Diffuse Large B‐Cell Lymphoma in Malawi: A Prospective CohortThomas C Shea, Yuri Fedoriw, British Journal of Haematology
Press Mentions
Management of Recurrent Prostate Cancer After Radiotherapy: Long-Term Results from CALGB 9687 (Alliance), a Prospective Multi-Institutional Salvage Prostatectomy SeriesNovember 1st, 2018
Grant Support
- Cancer And Leukemia Group BNational Cancer Institute1994–2012
- Core--Protocol Review And Monitoring SystemNational Cancer Institute2005–2009
- Pharmacodynamic Modeling Of Oral Etoposide In Relapsed NON HodgkinsNational Center For Research Resources1999–2002
- Filgrastim Alone Or In Combination W/ R Methuscf In Breast CancerNational Center For Research Resources1999–2002
- Core--Clinical ProtocolNational Cancer Institute2000
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
